Haloperidol
Back to searchMolecule Structure
Scientific Name
Haloperidol
Description of the Drug
Haloperidol is an antipsychotic agent used to treat schizophrenia and other psychoses, as well as symptoms of agitation, irritability, and delirium.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00502
http://www.drugbank.ca/drugs/DB00502
Brand Name(s)
Dolpin, Dozic, Fortunan, Haldol, Haldol solutab, Haloperidol, Kentace, Keselen, Serenace
Company Owner(s)
Solopak Medical Products Inc, Watson Laboratories Inc, Actavis Mid Atlantic Llc, Mylan Pharmaceuticals Inc, Purepac Pharmaceutical Co, Scs Pharmaceuticals, Zydus Pharmaceuticals Usa Inc, Akorn Operating Co Llc, Vintage Pharmaceuticals Llc, Royce Laboratories Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| D2-like dopamine receptor | PROTEIN FAMILY | INVERSE AGONIST | CHEMBL2331075 |
| Serotonin 2a (5-HT2a) receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL224 |
Clinical Trial(s)
Unichem Links
| Atlas | haloperidol | ||
| SureChEMBL | SCHEMBL8264 | ||
| PharmGKB | PA449841 | ||
| Human Metabolome Database | HMDB0014645 | ||
| DrugBank | DB00502 | ||
| PubChem: Thomson Pharma | 14902191 | ||
| PubChem | 3559 | ||
| Mcule | MCULE-3693790133 | ||
| NMRShiftDB | 20207509 | ||
| LINCS | LSM-3512 | ||
| Nikkaji | J1.365J | ||
| PDBe | GMJ | ||
| BindingDB | 21398 | ||
| EPA CompTox Dashboard | DTXSID4034150 | ||
| DrugCentral | 1353 | ||
| Brenda | 78069 | 75627 | 3539 |
| ChemicalBook | CB7774829 | CB32131152 | CB72509133 |
| Guide to Pharmacology | 86 | ||
| rxnorm | HALDOL | HALOPERIDOL | HALOPERIDOL LACTATE |
| PubChem: Drugs of the Future | 12013409 | ||
| KEGG Ligand | C01814 | ||
| ChEBI | 5613 | ||
| ZINC | ZINC000000537822 |
